**Background of GKAP1 Antibody**
GKAP1 (G Kinase Anchoring Protein 1), also known as AKAP1 or DAKAP1. is a member of the A-kinase anchoring protein (AKAP) family, which plays a critical role in organizing signaling complexes by tethering protein kinase A (PKA) and other enzymes to specific subcellular compartments. GKAP1 is primarily localized to mitochondria and the endoplasmic reticulum, where it regulates mitochondrial dynamics, apoptosis, and energy metabolism by anchoring PKA to modulate phosphorylation events.
Antibodies targeting GKAP1 are essential tools for studying its expression, localization, and functional interactions in cellular signaling pathways. They are widely used in techniques such as Western blotting, immunofluorescence, and immunoprecipitation to investigate GKAP1's role in diseases linked to mitochondrial dysfunction, including neurodegenerative disorders, cardiovascular diseases, and cancer.
GKAP1 antibodies are typically validated for specificity using knockout or knockdown controls, ensuring accurate detection of the ~80 kDa protein. Commercial variants include monoclonal and polyclonal options, often developed in hosts like rabbits or mice. Research utilizing these antibodies has highlighted GKAP1's involvement in stress responses and its potential as a therapeutic target for metabolic and age-related conditions.